nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C9—Estropipate—osteoporosis	0.153	0.178	CbGbCtD
Pyrimethamine—CYP2C8—Raloxifene—osteoporosis	0.147	0.17	CbGbCtD
Pyrimethamine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.142	0.165	CbGbCtD
Pyrimethamine—CYP2C8—Cholecalciferol—osteoporosis	0.113	0.132	CbGbCtD
Pyrimethamine—CYP2C8—Estradiol—osteoporosis	0.0912	0.106	CbGbCtD
Pyrimethamine—CYP2C9—Cholecalciferol—osteoporosis	0.0789	0.0917	CbGbCtD
Pyrimethamine—CYP2D6—Cholecalciferol—osteoporosis	0.0722	0.0839	CbGbCtD
Pyrimethamine—CYP2C9—Estradiol—osteoporosis	0.0636	0.0739	CbGbCtD
Pyrimethamine—DHFR—One Carbon Metabolism—ATIC—osteoporosis	0.0046	0.118	CbGpPWpGaD
Pyrimethamine—Haematuria—Calcium Acetate—osteoporosis	0.00431	0.043	CcSEcCtD
Pyrimethamine—Pancytopenia—Etidronic acid—osteoporosis	0.00316	0.0315	CcSEcCtD
Pyrimethamine—DHFR—Metabolism of folate and pterines—MTHFR—osteoporosis	0.00298	0.0762	CbGpPWpGaD
Pyrimethamine—Toxic epidermal necrolysis—Alendronate—osteoporosis	0.00296	0.0295	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.00294	0.0293	CcSEcCtD
Pyrimethamine—Anorexia—Calcium Acetate—osteoporosis	0.00275	0.0274	CcSEcCtD
Pyrimethamine—Erythema multiforme—Etidronic acid—osteoporosis	0.00252	0.0251	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00251	0.025	CcSEcCtD
Pyrimethamine—Decreased appetite—Calcium Acetate—osteoporosis	0.00251	0.025	CcSEcCtD
Pyrimethamine—Anorexia—Ergocalciferol—osteoporosis	0.00243	0.0242	CcSEcCtD
Pyrimethamine—Decreased appetite—Ergocalciferol—osteoporosis	0.00222	0.0221	CcSEcCtD
Pyrimethamine—Erythema multiforme—Estropipate—osteoporosis	0.00218	0.0217	CcSEcCtD
Pyrimethamine—Erythema multiforme—Alendronate—osteoporosis	0.00215	0.0214	CcSEcCtD
Pyrimethamine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00213	0.0212	CcSEcCtD
Pyrimethamine—Leukopenia—Etidronic acid—osteoporosis	0.00208	0.0207	CcSEcCtD
Pyrimethamine—Erythema multiforme—Calcitriol—osteoporosis	0.00205	0.0204	CcSEcCtD
Pyrimethamine—Pancytopenia—Zoledronate—osteoporosis	0.00188	0.0187	CcSEcCtD
Pyrimethamine—Haematuria—Pamidronate—osteoporosis	0.00184	0.0183	CcSEcCtD
Pyrimethamine—Vomiting—Calcium Acetate—osteoporosis	0.00183	0.0183	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00177	0.0176	CcSEcCtD
Pyrimethamine—Haematuria—Zoledronate—osteoporosis	0.00168	0.0168	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Estropipate—osteoporosis	0.00164	0.0163	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Ibandronate—osteoporosis	0.00157	0.0157	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Raloxifene—osteoporosis	0.00155	0.0155	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Calcitriol—osteoporosis	0.00154	0.0153	CcSEcCtD
Pyrimethamine—Anorexia—Calcitriol—osteoporosis	0.00147	0.0146	CcSEcCtD
Pyrimethamine—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00144	0.0144	CcSEcCtD
Pyrimethamine—Hypersensitivity—Etidronic acid—osteoporosis	0.0014	0.0139	CcSEcCtD
Pyrimethamine—Decreased appetite—Ibandronate—osteoporosis	0.00137	0.0136	CcSEcCtD
Pyrimethamine—Leukopenia—Pamidronate—osteoporosis	0.00135	0.0135	CcSEcCtD
Pyrimethamine—Decreased appetite—Calcitriol—osteoporosis	0.00134	0.0133	CcSEcCtD
Pyrimethamine—Haematuria—Estradiol—osteoporosis	0.0013	0.0129	CcSEcCtD
Pyrimethamine—Leukopenia—Zoledronate—osteoporosis	0.00123	0.0123	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Pamidronate—osteoporosis	0.00123	0.0123	CcSEcCtD
Pyrimethamine—Hypersensitivity—Estropipate—osteoporosis	0.00121	0.012	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Pamidronate—osteoporosis	0.00121	0.012	CcSEcCtD
Pyrimethamine—Vomiting—Etidronic acid—osteoporosis	0.0012	0.012	CcSEcCtD
Pyrimethamine—DHFR—One Carbon Metabolism—MTHFR—osteoporosis	0.0012	0.0307	CbGpPWpGaD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.0012	0.0306	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Alendronate—osteoporosis	0.00119	0.0119	CcSEcCtD
Pyrimethamine—Anorexia—Pamidronate—osteoporosis	0.00117	0.0117	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ibandronate—osteoporosis	0.00116	0.0115	CcSEcCtD
Pyrimethamine—Erythema multiforme—Estradiol—osteoporosis	0.00115	0.0115	CcSEcCtD
Pyrimethamine—Hypersensitivity—Calcitriol—osteoporosis	0.00113	0.0113	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Zoledronate—osteoporosis	0.00112	0.0112	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Zoledronate—osteoporosis	0.0011	0.011	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00108	0.0108	CcSEcCtD
Pyrimethamine—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00108	0.0276	CbGpPWpGaD
Pyrimethamine—Anorexia—Zoledronate—osteoporosis	0.00107	0.0107	CcSEcCtD
Pyrimethamine—Decreased appetite—Pamidronate—osteoporosis	0.00107	0.0107	CcSEcCtD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00105	0.027	CbGpPWpGaD
Pyrimethamine—Vomiting—Estropipate—osteoporosis	0.00104	0.0104	CcSEcCtD
Pyrimethamine—Anorexia—Conjugated Estrogens—osteoporosis	0.00103	0.0103	CcSEcCtD
Pyrimethamine—Vomiting—Alendronate—osteoporosis	0.00103	0.0102	CcSEcCtD
Pyrimethamine—Vomiting—Raloxifene—osteoporosis	0.00101	0.0101	CcSEcCtD
Pyrimethamine—Vomiting—Ibandronate—osteoporosis	0.000999	0.00996	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000979	0.00975	CcSEcCtD
Pyrimethamine—Vomiting—Calcitriol—osteoporosis	0.000978	0.00975	CcSEcCtD
Pyrimethamine—Decreased appetite—Zoledronate—osteoporosis	0.000978	0.00974	CcSEcCtD
Pyrimethamine—Hypersensitivity—Risedronate—osteoporosis	0.000954	0.00951	CcSEcCtD
Pyrimethamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000941	0.00938	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pamidronate—osteoporosis	0.000907	0.00904	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Estradiol—osteoporosis	0.000867	0.00864	CcSEcCtD
Pyrimethamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000845	0.00842	CcSEcCtD
Pyrimethamine—Hypersensitivity—Zoledronate—osteoporosis	0.000829	0.00826	CcSEcCtD
Pyrimethamine—Vomiting—Risedronate—osteoporosis	0.000823	0.00821	CcSEcCtD
Pyrimethamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000798	0.00795	CcSEcCtD
Pyrimethamine—Vomiting—Pamidronate—osteoporosis	0.000783	0.0078	CcSEcCtD
Pyrimethamine—Decreased appetite—Estradiol—osteoporosis	0.000753	0.00751	CcSEcCtD
Pyrimethamine—Vomiting—Zoledronate—osteoporosis	0.000715	0.00713	CcSEcCtD
Pyrimethamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000688	0.00686	CcSEcCtD
Pyrimethamine—DHFR—Folate Metabolism—SOD2—osteoporosis	0.000687	0.0176	CbGpPWpGaD
Pyrimethamine—DHFR—G1/S Transition—PSMA2—osteoporosis	0.000665	0.017	CbGpPWpGaD
Pyrimethamine—DHFR—G1/S Transition—PSMA5—osteoporosis	0.000665	0.017	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—GPX1—osteoporosis	0.000656	0.0168	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Estradiol—osteoporosis	0.000638	0.00636	CcSEcCtD
Pyrimethamine—DHFR—Folate Metabolism—MTHFR—osteoporosis	0.000605	0.0155	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00056	0.0143	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00056	0.0143	CbGpPWpGaD
Pyrimethamine—Vomiting—Estradiol—osteoporosis	0.000551	0.00549	CcSEcCtD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000511	0.0131	CbGpPWpGaD
Pyrimethamine—CYP2C8—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000505	0.0129	CbGpPWpGaD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000485	0.0124	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00042	0.0107	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000416	0.0106	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000415	0.0106	CbGpPWpGaD
Pyrimethamine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000414	0.0106	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000411	0.0105	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—IL1B—osteoporosis	0.000359	0.00919	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00034	0.00871	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000337	0.00863	CbGpPWpGaD
Pyrimethamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000301	0.0077	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000269	0.00687	CbGpPWpGaD
Pyrimethamine—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000265	0.00678	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—TNF—osteoporosis	0.000261	0.00667	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—MYC—osteoporosis	0.000258	0.0066	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PKM—osteoporosis	0.000253	0.00648	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SOST—osteoporosis	0.000253	0.00648	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	0.000253	0.00647	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ANTXR2—osteoporosis	0.00024	0.00614	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PGLS—osteoporosis	0.00024	0.00614	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000224	0.00574	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000221	0.00564	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	0.00022	0.00563	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000219	0.00559	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000218	0.00557	CbGpPWpGaD
Pyrimethamine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000218	0.00557	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	0.000217	0.00556	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000216	0.00552	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PKM—osteoporosis	0.000212	0.00543	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—FDPS—osteoporosis	0.000212	0.00543	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—IL6—osteoporosis	0.00021	0.00538	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000206	0.00527	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000205	0.00525	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000205	0.00525	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—GSN—osteoporosis	0.000204	0.00522	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PGLS—osteoporosis	0.000201	0.00514	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GPD2—osteoporosis	0.000201	0.00514	CbGpPWpGaD
Pyrimethamine—DHFR—G1/S Transition—MYC—osteoporosis	0.000187	0.00479	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ATIC—osteoporosis	0.000184	0.00471	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PNP—osteoporosis	0.000184	0.00471	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—PSMA2—osteoporosis	0.000184	0.0047	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—PSMA5—osteoporosis	0.000184	0.0047	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000181	0.00462	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000179	0.00458	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000179	0.00457	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000178	0.00456	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—LRP5—osteoporosis	0.000178	0.00454	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000177	0.00453	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000177	0.00452	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—LRP6—osteoporosis	0.00017	0.00435	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RPL24—osteoporosis	0.000163	0.00418	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—LTF—osteoporosis	0.000163	0.00418	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000161	0.00413	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000158	0.00404	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—OXCT1—osteoporosis	0.000156	0.004	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CA2—osteoporosis	0.000156	0.004	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MGLL—osteoporosis	0.000152	0.0039	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000147	0.00377	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ACP5—osteoporosis	0.000142	0.00362	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00014	0.00357	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000133	0.00339	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TPI1—osteoporosis	0.000132	0.00337	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000131	0.00336	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000131	0.00335	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—IDH2—osteoporosis	0.00013	0.00332	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—P4HB—osteoporosis	0.000124	0.00316	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP27A1—osteoporosis	0.000122	0.00312	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—GAPDH—osteoporosis	0.000121	0.00311	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00012	0.00307	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ACP5—osteoporosis	0.000119	0.00303	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	0.000116	0.00296	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NFATC1—osteoporosis	0.000115	0.00295	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—DKK1—osteoporosis	0.000114	0.00293	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	0.000114	0.00292	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000114	0.00291	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—WNT1—osteoporosis	0.00011	0.00282	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TPI1—osteoporosis	0.00011	0.00282	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000109	0.00278	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000107	0.00275	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FGA—osteoporosis	0.000107	0.00274	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000107	0.00272	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000106	0.00271	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—P4HB—osteoporosis	0.000104	0.00265	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GAPDH—osteoporosis	0.000102	0.0026	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—RAP1A—osteoporosis	9.91e-05	0.00253	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ENO1—osteoporosis	9.56e-05	0.00245	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	9.5e-05	0.00243	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PSMA5—osteoporosis	9.42e-05	0.00241	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PSMA2—osteoporosis	9.42e-05	0.00241	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	9.41e-05	0.00241	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	9.37e-05	0.0024	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	9.29e-05	0.00238	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.83e-05	0.00226	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CALCA—osteoporosis	8.78e-05	0.00225	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.61e-05	0.0022	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.46e-05	0.00216	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ENO1—osteoporosis	8.01e-05	0.00205	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KL—osteoporosis	7.97e-05	0.00204	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PSMA2—osteoporosis	7.89e-05	0.00202	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PSMA5—osteoporosis	7.89e-05	0.00202	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.19e-05	0.00184	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—POMC—osteoporosis	6.95e-05	0.00178	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.88e-05	0.00176	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PKM—osteoporosis	6.56e-05	0.00168	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FDPS—osteoporosis	6.56e-05	0.00168	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP19A1—osteoporosis	6.4e-05	0.00164	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ADCY5—osteoporosis	6.25e-05	0.0016	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PGLS—osteoporosis	6.22e-05	0.00159	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPD2—osteoporosis	6.22e-05	0.00159	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.85e-05	0.0015	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MYC—osteoporosis	5.79e-05	0.00148	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTHFR—osteoporosis	5.74e-05	0.00147	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—POMC—osteoporosis	5.71e-05	0.00146	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PNP—osteoporosis	5.69e-05	0.00145	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ATIC—osteoporosis	5.69e-05	0.00145	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—POMC—osteoporosis	5.66e-05	0.00145	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IRS2—osteoporosis	5.46e-05	0.0014	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PKM—osteoporosis	5.38e-05	0.00138	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FDPS—osteoporosis	5.38e-05	0.00138	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PKM—osteoporosis	5.34e-05	0.00137	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FDPS—osteoporosis	5.34e-05	0.00137	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ADCY5—osteoporosis	5.23e-05	0.00134	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GPX1—osteoporosis	5.21e-05	0.00133	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MYC—osteoporosis	5.18e-05	0.00132	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PGLS—osteoporosis	5.1e-05	0.00131	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPD2—osteoporosis	5.1e-05	0.00131	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPD2—osteoporosis	5.06e-05	0.00129	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PGLS—osteoporosis	5.06e-05	0.00129	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CA2—osteoporosis	4.83e-05	0.00124	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—OXCT1—osteoporosis	4.83e-05	0.00124	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MTHFR—osteoporosis	4.81e-05	0.00123	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IRS1—osteoporosis	4.77e-05	0.00122	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MGLL—osteoporosis	4.71e-05	0.0012	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PNP—osteoporosis	4.67e-05	0.00119	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ATIC—osteoporosis	4.67e-05	0.00119	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ATIC—osteoporosis	4.63e-05	0.00118	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PNP—osteoporosis	4.63e-05	0.00118	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6R—osteoporosis	4.48e-05	0.00115	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.44e-05	0.00114	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—IDH2—osteoporosis	4.01e-05	0.00102	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA2—osteoporosis	3.97e-05	0.00102	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—OXCT1—osteoporosis	3.97e-05	0.00102	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA2—osteoporosis	3.93e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—OXCT1—osteoporosis	3.93e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MGLL—osteoporosis	3.87e-05	0.000989	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—POMC—osteoporosis	3.85e-05	0.000984	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MGLL—osteoporosis	3.83e-05	0.000981	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.77e-05	0.000963	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ACP5—osteoporosis	3.66e-05	0.000937	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.62e-05	0.000925	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.62e-05	0.000925	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TPI1—osteoporosis	3.41e-05	0.000871	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—IDH2—osteoporosis	3.29e-05	0.000841	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—IDH2—osteoporosis	3.26e-05	0.000834	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—P4HB—osteoporosis	3.2e-05	0.000819	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GAPDH—osteoporosis	3.14e-05	0.000804	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.09e-05	0.000791	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP27A1—osteoporosis	3.07e-05	0.000784	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—RAP1A—osteoporosis	3.06e-05	0.000783	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACP5—osteoporosis	3.01e-05	0.000769	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACP5—osteoporosis	2.98e-05	0.000763	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.94e-05	0.000753	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TPI1—osteoporosis	2.8e-05	0.000715	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TPI1—osteoporosis	2.77e-05	0.000709	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.67e-05	0.000683	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—osteoporosis	2.66e-05	0.000679	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—osteoporosis	2.65e-05	0.000678	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—P4HB—osteoporosis	2.63e-05	0.000672	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—P4HB—osteoporosis	2.61e-05	0.000667	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.58e-05	0.00066	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GAPDH—osteoporosis	2.56e-05	0.000654	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—RAP1A—osteoporosis	2.51e-05	0.000643	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—RAP1A—osteoporosis	2.49e-05	0.000637	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ENO1—osteoporosis	2.47e-05	0.000633	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PSMA2—osteoporosis	2.44e-05	0.000624	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PSMA5—osteoporosis	2.44e-05	0.000624	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.17e-05	0.000556	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ENO1—osteoporosis	2.03e-05	0.00052	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ENO1—osteoporosis	2.01e-05	0.000515	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PSMA2—osteoporosis	2e-05	0.000512	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PSMA5—osteoporosis	2e-05	0.000512	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—osteoporosis	2e-05	0.000511	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.98e-05	0.000508	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.98e-05	0.000508	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.98e-05	0.000506	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.62e-05	0.000415	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADCY5—osteoporosis	1.62e-05	0.000413	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—osteoporosis	1.61e-05	0.000412	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.61e-05	0.000412	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—osteoporosis	1.49e-05	0.00038	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.33e-05	0.000339	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—osteoporosis	1.32e-05	0.000338	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADCY5—osteoporosis	1.32e-05	0.000336	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—osteoporosis	1.31e-05	0.000335	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.22e-05	0.000312	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—osteoporosis	1.21e-05	0.000309	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—POMC—osteoporosis	1.19e-05	0.000304	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—POMC—osteoporosis	9.76e-06	0.00025	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—POMC—osteoporosis	9.68e-06	0.000248	CbGpPWpGaD
